Toll-Like Receptors as Therapeutic Targets in Central Nervous System Tumors

In recent years, progress has been made in understanding the pathological, genetic, and molecular heterogeneity of central nervous system (CNS) tumors. However, improvements in risk classification, prognosis, and treatment have not been sufficient. Currently, great importance has been placed to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Abarca-Merlin, D. M., Maldonado-Bernal, C., Alvarez-Arellano, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556293/
https://www.ncbi.nlm.nih.gov/pubmed/31240216
http://dx.doi.org/10.1155/2019/5286358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556293/
https://www.ncbi.nlm.nih.gov/pubmed/31240216
http://dx.doi.org/10.1155/2019/5286358

Ejemplares similares